NEW YORK (GenomeWeb News) – Luminex has closed its public offering of 4,025,000 shares of common stock, including the over-allotment option of 525,000 shares, raising roughly $74.3 million in net proceeds.
 
The offering was priced at $19.91 per share, which was Luminex’s closing price on June 24. In late Monday afternoon trade, the firm’s shares were down .5 percent at $20.68.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.